Long-term adherence to antihypertensive therapy: A survey in four primary care clinics

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 8, 2008, Pages 1271-1277

  Vinker, Shlomo ^a,b   Alkalay, Adi ^a   Hoffman, Robert D ^c   Elhayany, Asher ^a   Kaiserman, Igor ^d   Kitai, Eliezer ^a,e  

^a CLALIT HEALTH SERVICES   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

^d BARZILAI MEDICAL CENTER   (Israel)

^e Department of Family Medicine   (Israel)

Author keywords

blocker; blocker; ACEI; Adherence; Angiotensin receptor blocker; Angiotensin converting enzyme inhibitor; ARB; Family physician; Hypertension; Medical record; Non compliance

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; IMMIGRATION; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT; BLOOD PRESSURE; CLINICAL PRACTICE; DRUG EFFECT; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; ISRAEL; LONGITUDINAL STUDY; MIDDLE AGED; MIGRATION; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; SOCIOECONOMICS; STATISTICS; TIME; TREATMENT REFUSAL; URBAN POPULATION;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EMIGRANTS AND IMMIGRANTS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH SURVEYS; HUMANS; HYPERTENSION; ISRAEL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT REFUSAL; URBAN POPULATION;

EID: 45549107225     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.9.8.1271     Document Type: Article

References (28)

1. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001;3:404-8
2. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-81
3. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990;82:1616-28
4. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002;361:1391
5. Vasan RS, Beiser A, Seshadri S, et al. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men. The Framingham Heart Study. JAMA 2002;287:1003-10
6. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs: results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialsists' Collaboration. Lancet 2000;356:1955-64
7. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002;4:393-404
8. Black HR, Elliott WJ, Neaton JD, et al. Baseline characteristics and early blood pressure control in the CONVINCE trial. Hypertension 2001;37:12-8
9. Lenfant C, Chobanian AV, Jones DW, et al. Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003;41:1178-9
10. Wuerzner K, Hassler C, Burnier M. Difficult blood pressure control: watch out for non-compliance! Nephrol Dial Transplant 2003;18:1969-73
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97
12. Barrier PA, Li JT, Jensen NM. Two words to improve physician-patient communication: what else? Mayo Clin Proc 2003;78:211-4
13. Gascón JJ, Sánchez-Ortuño M, Llor B, et al. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract 2004;21:125-30
14. Chobanian AV, Bakris GL, Black HR, et al. Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. national heart, lung, and blood institute; national high blood pressure education program coordinating committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52
15. Hasford J, Schröder-Bernhardi D, Rottenkolber M, et al. Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 2007;63:1055-61
16. Munger MA, Van Tassel BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007;9:58
17. Fung V, Huang J, Brand R, et al. Hypertension treatment in a medicare population: adherence and systolic blood pressure control. Clin Ther 2007;29:972-84
18. Hill MN, Miller NH. Compliance enhancement. A call for multidisciplinary team approaches. Circulation 1996;93:4-6
19. Marentette MA, Gerth WC, Billings DK, et al. Antihypertensive persistence and drug class. Can J Cardiol 2002;18:649-56
20. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 2002;24:1347-57
21. Delgi Esposti L, Di Martino M, Saragoni S, et al. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens (Greenwich) 2004;6:76-84
22. Di Martino M, Veronesi C, Degli Esposti L, et al. Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in Italy. J Hum Hypertens 2008;22:51-3
23. Wogen J, Kreilick CA, Livornese RC, et al. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm 2003;9:424-9
24. Raji MA, Kuo YF, Salazar JA, et al. Ethnic differences in antihypertensive medication use in the elderly. Ann Pharmacother 2004;38:209-14
25. Billups SJ, Malone DC, Carrer BL. The relationship between drug therapy noncompliance and patient characteristics. Health related quality of life, and health care costs. Pharmacotherapy 2000;20:941-9
26. Vargara C, Martin AM, Wang F, et al. Awareness about factors that affect the management of hypertension in Puerto Rican patients. Conn Med 2004;68:269-76
27. Betancourt JR, Camilo JE, Green AR. Hypertension in multicultural and minority populations: linking communication to compliance. Curr Hypertens Rep 1999;1:482-8
28. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Sys Rev 2004:CD004804